BRIEF published on 03/11/2026 at 18:35, 8 months 5 days ago Inoviem Scientific Advances Développement de médicaments avec une approche centrée sur le patient Médecine Personnalisée Innovation Pharmaceutique Inoviem Scientifique Développement De Médicaments Centré Sur Le Patient Programmes Précliniques
BRIEF published on 03/11/2026 at 18:35, 8 months 5 days ago Inoviem Scientific Advances Drug Development with Patient-Centric Approach Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
PRESS RELEASE published on 03/11/2026 at 18:30, 8 months 5 days ago ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF published on 03/11/2026 at 18:20, 8 months 5 days ago Inoviem Scientific: Advances in Pharmaceutical Development Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
BRIEF published on 03/11/2026 at 18:20, 8 months 5 days ago Inoviem Scientific : Avancées dans le Développement Pharmaceutique Médecine Personnalisée Développement Pharmaceutique Pharmacologie Translationnelle Inoviem Scientific Plateforme Intégrée
PRESS RELEASE published on 03/11/2026 at 18:15, 8 months 5 days ago ATON : POINT D'AVANCEMENT SUR L'ACTIVITÉ DE LA FILIALE INOVIEM SCIENTIFIC Le Groupe Aton via sa filiale Inoviem Scientific innove dans le développement de médicaments en utilisant des échantillons de patients pour des analyses moléculaires assistées par IA Médecine Personnalisée Développement Pharmaceutique Groupe Aton Innovation Thérapeutique Inoviem Scientific
BRIEF published on 02/18/2026 at 18:35, 8 months 26 days ago Hadrien Lanvin appointed Deputy Managing Director of the Aton Group Biotechnology Life Sciences Appointment Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 8 months 26 days ago Hadrien Lanvin nommé directeur général adjoint du groupe Aton Biotechnologie Croissance Stratégique Directeur Général Adjoint Groupe Aton Hadrien Lanvin
BRIEF published on 02/18/2026 at 18:35, 8 months 26 days ago Hadrien Lanvin Appointed Deputy CEO of Aton Group Biotechnology Strategic Growth Deputy CEO Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 8 months 26 days ago Hadrien Lanvin nommé Directeur général délégué du Groupe Aton Biotechnologie Nomination Sciences De La Vie Groupe Aton Hadrien Lanvin
Published on 11/17/2026 at 02:05, 4 hours 36 minutes ago BioNxt Solutions Inc. Announces Non-Brokered Private Placement of Units
Published on 11/17/2026 at 01:30, 5 hours 11 minutes ago NXT Energy Solutions Announces Third Quarter 2026 Results
Published on 11/17/2026 at 00:25, 6 hours 16 minutes ago Core Critical Metals Corp. Announces Upsize of Non-Brokered Critical Mineral Flow-Through Private Placement to $750,000
Published on 11/16/2026 at 23:30, 7 hours 11 minutes ago Avidian Gold Announces Results of Annual General and Special Meeting and Officer Resignation
Published on 11/16/2026 at 23:30, 7 hours 11 minutes ago Northern Dynasty Announces Results of Governance Committee Review and Supplemental Director Disclosure
Published on 11/17/2026 at 06:30, 11 minutes ago Reignwood Park shines on global stage with triple win at World Golf Awards 2026
Published on 11/17/2026 at 06:30, 11 minutes ago Two Blockbusters, Two Niche-Busters, One Smart Portfolio: Formycon Names Tezspire® and Hemlibra® as Reference Drugs
Published on 11/17/2026 at 06:05, 36 minutes ago From "Era of Resource Competition" to "Era of Resource Creation": Future of Hydrogen Society Discussed at Fuji Hydrogen Summit 2026 in Yamanashi
Published on 11/17/2026 at 05:45, 56 minutes ago Ayara Kamala Reveals a Refreshed Vision for Wellness in Phuket
Published on 11/16/2026 at 18:34, 12 hours 6 minutes ago SUEZ International SAS lance la cession d’environ 9,6 millions d’actions d’Acea
Published on 11/16/2026 at 18:07, 12 hours 33 minutes ago Reporting on share buyback transactions carried out between November 10 and November 13, 2026
Published on 11/16/2026 at 18:07, 12 hours 33 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre les 10 et 13 novembre 2026
Published on 11/16/2026 at 18:01, 12 hours 40 minutes ago Saint-Gobain has signed an agreement for the divestment of its pipe business in Latin America
Published on 11/16/2026 at 18:01, 12 hours 40 minutes ago Saint-Gobain signe un accord pour la cession de son activité canalisation en Amérique latine